NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Angstrom Bio, Inc.

Angstrom Bio, Inc.

Private
Austin, TexasHealthcare & Life Scienceshttps://angstrom.bio/

Last Round

VC Round

Jun 16, 2021

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Angstrom Bio, Inc. is a biotechnology company that develops a sequencing-based molecular diagnostics platform using nanopore sequencing and machine learning.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

molecular diagnosticsnanopore sequencingrespiratory pathogen detectionhigh-throughput testingviral variant detectionNGSclinical diagnosticsnext-gen sequencingmedical AIcomputational biologyAI diagnosticsprecision medicinediagnostic platformpathogen surveillancebiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Angstrom Bio, Inc. Comps

Public and private peers based on sector, stage, and business model.

Angstrom Bio, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Angstrom Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 16, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

David States

Co-Founder and Chief Medical Officer

Founding Team

Carlos Santos

Founder And CEO

Founding Team

Angstrom Bio, Inc. Investors

Notable investors and investment history

Angstrom Bio, Inc. investors
InvestorRounds
GreyBird VenturesVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 63% MoM.

  • Jun 16, 2021

    $3M round led by GreyBird Ventures.

View all signals

Angstrom Bio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Angstrom Bio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Angstrom Bio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range3
Year Founded2019
Last FundingJun 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.